NYSE:BSXMedical Equipment
Boston Scientific Recall And Lawsuits Weigh On Outlook And Valuation Gap
Boston Scientific’s AXIOS Stent and Delivery Systems are under a Class I recall following reports of serious injuries and fatalities.
The recall has coincided with securities fraud investigations and a class action lawsuit alleging misrepresentation of growth prospects and sales guidance.
These developments raise questions about regulatory oversight, legal exposure, and potential business impact for NYSE:BSX.
For investors watching Boston Scientific at a share price of $71.35, the Class I...